If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
380.00    30.00 (8.57%)
Bid:
370.00
Ask:
390.00
Spread: 20.00 (5.405%)
Market Cap: £36.31m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Debt refinancing

Today 07:00

RNS Number : 6910K
Cropper(James) PLC
02 July 2026
 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION PURSUANT TO ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

2 July 2026

 

James Cropper plc

("James Cropper", the "Company" or the "Group")

 

Debt refinancing

 

James Cropper plc (AIM: CRPR), the Advanced Materials and Paper & Packaging group, is pleased to announce the completion of a refinancing of its debt facilities. This refinancing provides the Group with a more flexible funding platform to support delivery of its medium-term strategic priorities.

 

The new arrangements improve the Group's cash flow and balance sheet flexibility through access to a new invoice discounting facility of up to £15m committed for at least three years, which provides flexible working capital funding to enable more efficient management of the Group's liquidity.

 

As part of the refinancing, the Group will make a part-repayment of £7.1m on its existing UK bank loan, funded from the Group's cash resources and the new invoice discounting facility, with the remaining balance repayable in reduced quarterly instalments through to March 2030.

 

In addition, the maturity of the Group's US bank loan has been extended by 12 months, with the final repayment of $3.2m deferred to December 2027, improving liquidity headroom during this period.

 

Alongside the debt refinancing, the Group has agreed to make a one-off contribution into its defined benefit pension schemes of £0.6m, with the previously agreed contribution schedule reduced by £0.35m in aggregate across the period to September 2027. In addition, the Group has agreed to bring forward the next triennial actuarial valuation of the pension schemes by 12 months to March 2027. 

 

Andrew Goody, Chief Financial Officer, said: "This refinancing builds on the significant progress we have made in strengthening the Group's balance sheet through improved operational performance and continued focus on cash and working capital management, with net debt at 28 March 2026 less than 1x adjusted EBITDA.

 

"The refinancing materially improves our liquidity and financial flexibility. By improving access to committed working capital funding and extending the maturity profile of our debt, the new arrangements provide greater headroom to support both operational requirements and strategic growth initiatives.

 

"Importantly, the refinancing allows us to deploy capital more efficiently, which we expect will allow the Group to reduce cash financing costs. I am grateful to our lending partners for their continued support and to HSBC Invoice Finance for helping deliver this important enhancement to our funding structure."

 

-END-

Enquiries

 

James Cropper plc

David Stirling, CEO

Andrew Goody, CFO

 

Tel: +44 (0)1539 722 002

Shore Capital - Nominated Adviser and Broker

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

 

Tel: +44 (0)207 408 4090

IFC Advisory - Financial PR

Graham Herring, Tim Metcalfe, Zach Cohen

Tel: +44 (0) 203 934 6630

james.cropper@investor-focus.co.uk

 

 

About James Cropper

 

James Cropper plc is globally recognised for its specialist capabilities in the design and manufacture of advanced materials and paper products. Operating through two principal businesses - Advanced Materials and Paper & Packaging - and built upon 180 years of innovation, the Group serves a diverse range of customers with high-performance solutions tailored to specialised applications.

 

The Advanced Materials business develops cutting-edge nonwoven materials and electrochemical coatings for sectors including aerospace, clean energy, and defence. The Paper & Packaging business offers premium creative papers and bespoke moulded fibre packaging together with leading recycled-fibre capabilities and products, supporting the transition to a circular economy.

 

Headquartered in Burneside (UK), with additional manufacturing sites in Crewe (UK), Launceston (UK), and Schenectady (USA), James Cropper leverages deep expertise in material science and longstanding partnerships with industry-leading businesses and brands to develop bespoke solutions that meet complex technical and aesthetic specifications.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFRDFILIIR
Date   Source Headline
22nd Jul 20162:26 pmRNSDirector/PDMR Shareholding
18th Jul 20164:13 pmRNSDirector/PDMR Shareholding
28th Jun 20167:00 amRNSFinal Results
13th Jun 20162:54 pmRNSHolding(s) in Company
3rd May 20165:07 pmRNSHolding(s) in Company
13th Apr 20163:25 pmRNSIssue of Equity
11th Apr 20163:39 pmRNSHolding(s) in Company
11th Apr 20167:00 amRNSTrading Update
31st Mar 20161:09 pmRNSDirector/PDMR Shareholding
20th Jan 20164:57 pmRNSDirector/PDMR Shareholding
19th Jan 20161:24 pmRNSDirector Dealing
7th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
23rd Dec 20157:00 amRNSIssue of Equity
16th Dec 20158:35 amRNSIssue of Equity
16th Dec 20157:00 amRNSDirector Dealing
15th Dec 20158:58 amRNSUpdate re Storm Desmond
8th Dec 20157:00 amRNSImpact of Storm Desmond
1st Dec 20154:59 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSIssue of Equity
24th Nov 20152:55 pmRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSIssue of Equity
16th Nov 201510:36 amRNSDirectors' Dealings and LTIP Award
10th Nov 20157:00 amRNSHalf Yearly Report
18th Sep 20153:04 pmRNSDirector/PDMR Shareholding
7th Sep 20152:25 pmRNSDirectors' Interests
21st Aug 20157:00 amRNSDirectors' Dealings and LTIP Award
4th Aug 20159:37 amRNSDirector/PDMR Shareholding
4th Aug 20157:01 amRNSHolding(s) in Company
3rd Aug 201511:48 amRNSDirectors' option interests
31st Jul 20154:35 pmRNSHolding(s) in Company
29th Jul 201511:00 amRNSAGM and Trading Update
28th Jul 20158:55 amRNSDirectors' interests
16th Jul 20158:24 amRNSDirector/PDMR Shareholding
14th Jul 20158:33 amRNSDirector Dealing
8th Jul 20154:42 pmRNSDirector/PDMR Shareholding
24th Jun 20157:00 amRNSFinal Dividend - ex-date correction
23rd Jun 20157:00 amRNSFinal Results
1st Jun 20159:16 amRNSDirectors' interests
19th May 20154:25 pmRNSDirector/PDMR Shareholding
8th May 20157:00 amRNSIssue of Equity
29th Apr 20157:00 amRNSIssue of Equity
31st Mar 201512:44 pmRNSDirectors' option interests
9th Mar 20152:31 pmRNSReplacement - Director/PDMR Shareholding
6th Feb 201510:28 amRNSDirector Shareholding
13th Jan 20159:46 amRNSHolding(s) in Company
8th Dec 20147:00 amRNSDirector/PDMR Shareholding
3rd Dec 20147:00 amRNSIssue of Equity
19th Nov 20144:23 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSIssue of equity and director dealings
11th Nov 20147:00 amRNSHalf-year results to 27 September 2014

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.